发明申请
US20050032738A1 Method of treating cancer by conjunctive therapy with 2'-haloemethylidene derivatives and a S-phase or M-phase specific antineoplastic agent
审中-公开
用2'-卤代亚乙基衍生物和S期或M期特异性抗肿瘤药联合治疗癌症的方法
- 专利标题： Method of treating cancer by conjunctive therapy with 2'-haloemethylidene derivatives and a S-phase or M-phase specific antineoplastic agent
- 专利标题（中）： 用2'-卤代亚乙基衍生物和S期或M期特异性抗肿瘤药联合治疗癌症的方法
-
申请号： US10943429申请日： 2004-09-17
-
公开(公告)号： US20050032738A1公开(公告)日： 2005-02-10
- 发明人: Sai Sunkara
- 申请人： Sai Sunkara
- 申请人地址： US NJ Bridgewater
- 专利权人： Merrell Pharmaceuticals Inc.
- 当前专利权人： Merrell Pharmaceuticals Inc.
- 当前专利权人地址： US NJ Bridgewater
- 主分类号： C07D239/54
- IPC分类号： C07D239/54 ; A61K31/475 ; A61K31/505 ; A61K31/513 ; A61K31/7068 ; A61P35/00 ; A61P35/02 ; C07D405/04 ; C07D473/02 ; C07H19/04 ; C07H19/06 ; A61K31/7076 ; A61K31/519 ; A61K31/522 ; A61K31/7072
摘要：
The present invention relates to a method of treating a patient suffering from a neoplastic disease state comprising administering to said patient an effective antineoplastic amount of a 2′-halomethylidene derivative in conjunctive therapy with an effective antineoplastic amount of a S phase or M-phase specific agent.